ES403125A1 - Procedimiento para la obtencion de una composicion antibac-teriana. - Google Patents

Procedimiento para la obtencion de una composicion antibac-teriana.

Info

Publication number
ES403125A1
ES403125A1 ES403125A ES403125A ES403125A1 ES 403125 A1 ES403125 A1 ES 403125A1 ES 403125 A ES403125 A ES 403125A ES 403125 A ES403125 A ES 403125A ES 403125 A1 ES403125 A1 ES 403125A1
Authority
ES
Spain
Prior art keywords
translation
procedure
obtaining
formula
machine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES403125A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2025414A external-priority patent/DE2025414C3/de
Priority claimed from DE19712104580 external-priority patent/DE2104580C3/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES403125A1 publication Critical patent/ES403125A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
    • C07D499/68—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with aromatic rings as additional substituents on the carbon chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)

Abstract

Procedimiento para la obtención de una composición antibacteriana, caracterizado porque en una primera etapa se prepara una penicilina de fórmula general I. **fórmula** en la que R es fenilo, R'' es metilo y R''` es dimetilamino y en cuyos compuestos, en cuanto eal centro de quiralidad C*, pueden presentarse en las dos posibles configuraciones R y S y como mezclas de los diastereómeros de ellas resultantes, así como las sales atóxicas farmacéuticamente tolerables de estos compuestos , haciendo reaccionar un compuesto de fórmula general II **fórmula** en la que R se define como anteriormente , con un compuesto de fórmula general III **fórmula** en la que R'' y R''` se definen como anteriormente, y W representa halógeno o azido, efectuándose la reacción en disolvente anhidros o acuosos, en presencia de una base, y en una segunda etapa se mezcla la penicilina resultante con un vehículo farmacéuticamente aceptable.
ES403125A 1970-05-25 1972-05-24 Procedimiento para la obtencion de una composicion antibac-teriana. Expired ES403125A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2025414A DE2025414C3 (de) 1970-05-25 1970-05-25 Cyclische Acylureidophenylacetamidopenicillansäuren
DE19712104580 DE2104580C3 (de) 1971-02-01 1971-02-01 Acylureidopenicilline

Publications (1)

Publication Number Publication Date
ES403125A1 true ES403125A1 (es) 1975-12-16

Family

ID=25759178

Family Applications (4)

Application Number Title Priority Date Filing Date
ES391532A Expired ES391532A1 (es) 1970-05-25 1971-05-25 Procedimiento para la obtencion de penicilinas.
ES403126A Expired ES403126A1 (es) 1970-05-25 1972-05-24 Procedimiento para la obtencion de una composicion antibac-teriana.
ES403124A Expired ES403124A1 (es) 1970-05-25 1972-05-24 Procedimiento para la obtencion de una composicion antibac-teriana.
ES403125A Expired ES403125A1 (es) 1970-05-25 1972-05-24 Procedimiento para la obtencion de una composicion antibac-teriana.

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES391532A Expired ES391532A1 (es) 1970-05-25 1971-05-25 Procedimiento para la obtencion de penicilinas.
ES403126A Expired ES403126A1 (es) 1970-05-25 1972-05-24 Procedimiento para la obtencion de una composicion antibac-teriana.
ES403124A Expired ES403124A1 (es) 1970-05-25 1972-05-24 Procedimiento para la obtencion de una composicion antibac-teriana.

Country Status (28)

Country Link
JP (1) JPS5538357B1 (es)
AR (2) AR195267A1 (es)
AT (1) AT307617B (es)
BE (1) BE767647A (es)
BG (1) BG23220A3 (es)
CA (1) CA943128A (es)
CH (1) CH562249A5 (es)
CS (1) CS171230B2 (es)
CY (1) CY829A (es)
DD (1) DD91497B3 (es)
DK (1) DK133679C (es)
EG (1) EG10856A (es)
ES (4) ES391532A1 (es)
FI (1) FI54484C (es)
FR (1) FR2100681B1 (es)
GB (1) GB1301961A (es)
HU (1) HU162205B (es)
IE (1) IE35311B1 (es)
IL (1) IL36905A (es)
KE (1) KE2592A (es)
LU (1) LU63203A1 (es)
NL (1) NL172660C (es)
NO (1) NO141164C (es)
PH (1) PH14794A (es)
RO (2) RO59157A (es)
SE (1) SE395896B (es)
SU (1) SU472507A3 (es)
YU (1) YU130271A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2354219A1 (de) * 1973-10-30 1975-05-07 Bayer Ag Beta-lactam-antibiotica, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4039673A (en) 1973-10-30 1977-08-02 Bayer Aktiengesellschaft Penicillins and cephalosporins and their production
GB1486349A (en) * 1974-11-28 1977-09-21 Bayer Ag Beta-lactam antibiotics process for their preparation and their use as medicaments
GB1584400A (en) * 1976-12-24 1981-02-11 Bayer Ag (2-oxo-imidazoliden-1-yl(carbonylamino)-acetamido-cephalosporins and penicillins
DE2658906A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Beta-lactam-antibiotika, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
CA1133896A (en) * 1978-05-26 1982-10-19 Nobuhiro Oi Penicillanic acid derivative and process for preparing the same
JPS5732289A (en) 1980-08-05 1982-02-20 Chugai Pharmaceut Co Ltd Alpha-substituted ureidobenzylpenicillin

Also Published As

Publication number Publication date
DK133679C (da) 1976-11-15
NO141164B (no) 1979-10-15
RO59157A (es) 1976-04-15
FI54484C (fi) 1978-12-11
GB1301961A (es) 1973-01-04
DD91497A5 (de) 1972-07-20
YU130271A (en) 1982-02-25
EG10856A (en) 1977-05-31
CY829A (en) 1976-03-19
NL172660B (nl) 1983-05-02
IL36905A0 (en) 1971-07-28
RO62689A (fr) 1978-05-15
IL36905A (en) 1975-11-25
IE35311L (en) 1971-11-25
CH562249A5 (es) 1975-05-30
NO141164C (no) 1980-01-23
FR2100681B1 (es) 1974-10-18
JPS5538357B1 (es) 1980-10-03
AR195267A1 (es) 1973-09-28
CA943128A (en) 1974-03-05
PH14794A (en) 1981-12-09
NL7107175A (es) 1971-11-29
CS171230B2 (es) 1976-10-29
FR2100681A1 (es) 1972-03-24
NL172660C (nl) 1983-10-03
SU472507A3 (ru) 1975-05-30
DD91497B3 (de) 1988-01-27
DK133679B (da) 1976-06-28
HU162205B (es) 1973-01-29
KE2592A (en) 1976-01-09
LU63203A1 (es) 1971-09-01
BE767647A (es) 1971-11-25
BG23220A3 (bg) 1977-07-12
SE395896B (sv) 1977-08-29
ES403124A1 (es) 1976-01-01
AR195946A1 (es) 1973-11-15
FI54484B (fi) 1978-08-31
ES391532A1 (es) 1974-10-01
AT307617B (de) 1973-05-25
IE35311B1 (en) 1976-01-07
ES403126A1 (es) 1975-05-01

Similar Documents

Publication Publication Date Title
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
SE7604052L (sv) Nya erytromycinderivat och forfarande for framstellning derav
ES8600263A1 (es) Un compuesto.
ES425626A1 (es) Un procedimiento para preparar compuestos de acil-xilidida.
ES460040A1 (es) Un procedimiento para preparar derivados de 4-hidroxifeni- lalcanolaminas.
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
ES403124A1 (es) Procedimiento para la obtencion de una composicion antibac-teriana.
SE7411243L (es)
ES466851A1 (es) Procedimiento para la preparacion de 2-bromo-6-fluor-n-2- imidazolidinilidenbenzamina.
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
ES428295A1 (es) Procedimiento para la obtencion de derivados de canfeno sulfonados.
ES450897A1 (es) Procedimiento para la preparacion de n-(r-tetrahidrofurfu- ril)-noroximorfona y n-(s-tetrahidrofurfuril)-noroximorfona.
ES411675A1 (es) Procedimiento para la obtencion de composiciones antibacte-riales.
ES368955A1 (es) Procedimiento para preparar guanidinas sustituidas
GB1451902A (en) Bromo dihydrolysergic acid
ES294237A1 (es) Procedimiento para la produccion de una nueva sal soluble de eritromicina.
ES462843A1 (es) Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos.
ES412068A1 (es) Un procedimiento para la preparacion de compuestos anaste- sicos locales.
ES446187A1 (es) Un metodo de preparar nuevos compuestos de oxima-eter.
ES479234A1 (es) Procedimiento para la obtencion de derivados de antraquinona.
ES465346A1 (es) Procedimiento para preparar imidazoles 4,5-disustituidos.
ES367158A1 (es) Procedimiento para la preparacion de 3-fenil-imidazo-tia- zol.
ES376507A1 (es) Un procedimiento para preparar una composicion antidepresi-va a base de derivados de piperazina y quinoleina.
SE7606592L (sv) Nya aminobensoesyraderivat, forfarande for framstellning derav och farmaceutiska kompositioner innehallande dessa
FI762309A7 (es)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19910221